Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1501, 2005-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
No long-term QOL benefit for CRT
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 637, 2011-01 ,pp. :
Access to resources
Recommend
Long-term, low-intensity warfarin prevents recurrent VTE
Inpharma, Vol. 1, Iss. 1376, 2003-01 ,pp. :
Long-term safety of drug eluting stents: the debate continues
Reactions Weekly, Vol. 1, Iss. 1122, 2006-01 ,pp. :
Neoadjuvant chemotherapy: long-term benefit in osteosarcoma
Inpharma, Vol. 1, Iss. 1272, 2001-01 ,pp. :
Enfuvirtide-based treatment provides long-term benefit
Inpharma, Vol. 1, Iss. 1452, 2004-01 ,pp. :